Lant Intelligent: Dominating the e-cigarette market with innovation

Oct.16.2024
Lant Intelligent: Dominating the e-cigarette market with innovation
Investors questioned if Lantian Intelligent (300916.SZ) collaborates with various e-cigarette brands in the US market for competitive advantage.

On October 16th, an investor asked Lant Intelligent (stock code: 300916.SZ) on the investor interaction platform: Does the company have partnerships with e-cigarette brands such as RELX, SnowPlus, Yooz, Moti, Boede, Yooz, and Hqd ammo? Since the U.S. is the largest e-cigarette market, has the company participated in cross-border expansion or cooperated with overseas brands? What are the company's competitive advantages in this field?


Rant Intelligent responded by stating that the company currently has no business dealings with the brands you mentioned. The company's electronic atomizer device intelligent controllers are mainly exported indirectly through customers. With many years of dedicated work in the field of intelligent controllers, the company has accumulated extensive technical and production experience in the field of electronic atomizer device intelligent controllers. In recent years, the company has continuously worked with customers on technological innovation and product upgrades to meet the market's demand for products with high cost performance. At the same time, the company has excellent production capabilities, stable product quality, and the ability to supply large quantities, enabling rapid response to customer delivery demands.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The U.S. FDA is publicly recruiting members for its Tobacco Products Scientific Advisory Committee, with nominations accepted from both individuals and organizations
The U.S. FDA is publicly recruiting members for its Tobacco Products Scientific Advisory Committee, with nominations accepted from both individuals and organizations
The U.S. FDA is soliciting voting members for the Tobacco Products Scientific Advisory Committee, with the nomination deadline set for August 25, 2025. This recruitment aims to fill five vacancies, including experts in the fields of oncology, pulmonology, cardiology, and others, as well as one representative from the general public and one from government employees. Selected members will serve a term of up to four years, beginning on February 1, 2026.
Jul.31 by 2FIRSTS.ai
Product | ELFBAR Launches JOINOne Series Featuring Magnetic Design and Adjustable Cooling
Product | ELFBAR Launches JOINOne Series Featuring Magnetic Design and Adjustable Cooling
ELFBAR has launched the JOINOne series, featuring two pod types—“Dock-to-Vape” and “Standalone Use”—with three-level cooling adjustment. The Dynamic and Lumeo devices offer three power modes. The series debuted at the 2025 Dubai Vape Expo and is now available on ELFBAR’s website.
Jul.24 by 2FIRSTS.ai
Product | VOZOL Launches Two New E-Cigarettes with 40,000 Puffs and Four-Level Adjustable Output
Product | VOZOL Launches Two New E-Cigarettes with 40,000 Puffs and Four-Level Adjustable Output
VOZOL has launched two new e-cigarette models, VISTA 40K and STAR 40K, on its official website following their debut at the 2025 Dubai Expo. Featuring 40,000 puffs, a 1000mAh battery, “quantified” flavor descriptions, display screens, and S.i.L.C. Tech dual mesh coils, the devices are now available on UK distributor websites VapeSourcing and Vape Cave.
Jul.10
European Tobacco Tax Surge: Some Products See Increases of Up to 258%
European Tobacco Tax Surge: Some Products See Increases of Up to 258%
European tobacco taxes are set to rise sharply, with some products facing increases of up to 258%. Authorities are also considering including e-cigarettes in the tax framework to strengthen anti-smoking policies, aiming to generate an additional €15.1 billion (about $17.5 billion) in tax revenue.
Jun.16 by 2FIRSTS.ai
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
The FDA has launched the Commissioner’s National Priority Voucher (CNPV) program, reducing the review time for certain drugs to as little as 1–2 months. While the program currently applies only to pharmaceuticals, it demonstrates the FDA’s capacity to reform its review pathways. Whether a similar mechanism could extend to tobacco products now appears to be a matter of timing and technical details.
Jun.18
Swiss Parliament Advances Ban on Disposable E-Cigarettes; Motion Passed by National Council
Swiss Parliament Advances Ban on Disposable E-Cigarettes; Motion Passed by National Council
The Swiss National Council has passed a proposal to ban disposable e-cigarettes, which is now awaiting further review by the Senate.
Jun.05 by 2FIRSTS.ai